HeartSciences Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/32ebb0f4-de44-43da-8d7d-ad28459bb089/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-9.1M | 2025-05-01 – 2026-04-30 | evidence 0001437749-26-024337 |
| FY 2024 | $-8.8M | 2024-05-01 – 2025-04-30 | evidence 0000950170-25-098326 |
| FY 2023 | $-6.6M | 2023-05-01 – 2024-04-30 | evidence 0000950170-24-087271 |
| FY 2022 | $-6.4M | 2022-05-01 – 2023-04-30 | evidence 0000950170-23-033424 |
| FY 2021 | $-4.8M | 2021-05-01 – 2022-04-30 | evidence 0000950170-23-033424 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).